These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 11168639

  • 1. Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens.
    Kovarik J, Bozzotti P, Tougne C, Davis HL, Lambert PH, Krieg AM, Siegrist CA.
    Immunology; 2001 Jan; 102(1):67-76. PubMed ID: 11168639
    [Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll.
    Chelvarajan RL, Raithatha R, Venkataraman C, Kaul R, Han SS, Robertson DA, Bondada S.
    Eur J Immunol; 1999 Sep; 29(9):2808-18. PubMed ID: 10508255
    [Abstract] [Full Text] [Related]

  • 3. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 4. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G, Chen Q, Snapper CM.
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [Abstract] [Full Text] [Related]

  • 5. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes.
    Li WM, Bally MB, Schutze-Redelmeier MP.
    Vaccine; 2001 Oct 12; 20(1-2):148-57. PubMed ID: 11567759
    [Abstract] [Full Text] [Related]

  • 6. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
    Buchanan RM, Arulanandam BP, Metzger DW.
    J Immunol; 1998 Nov 15; 161(10):5525-33. PubMed ID: 9820529
    [Abstract] [Full Text] [Related]

  • 7. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD, Brazolot Millan CL, McCluskie MJ, Davis HL.
    FEMS Immunol Med Microbiol; 2001 Dec 15; 32(1):65-71. PubMed ID: 11750224
    [Abstract] [Full Text] [Related]

  • 8. T cell regulation of immunoglobulin class expression in the B cell response to TNP-Ficoll: characterization of the T cell responsible for preferential enhancement of the IgG2a response.
    Mongini PK, Longo DL, Paul WE.
    J Immunol; 1984 Apr 15; 132(4):1647-53. PubMed ID: 6230389
    [Abstract] [Full Text] [Related]

  • 9. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
    Thompson CB, Scher I, Schaefer ME, Lindsten T, Finkelman FD, Mond JJ.
    J Immunol; 1984 Nov 15; 133(5):2333-42. PubMed ID: 6207226
    [Abstract] [Full Text] [Related]

  • 10. Neonatal murine B lymphocytes respond to polysaccharide antigens in the presence of IL-1 and IL-6.
    Chelvarajan RL, Gilbert NL, Bondada S.
    J Immunol; 1998 Oct 01; 161(7):3315-24. PubMed ID: 9759847
    [Abstract] [Full Text] [Related]

  • 11. CpG DNA is an effective oral adjuvant to protein antigens in mice.
    McCluskie MJ, Weeratna RD, Krieg AM, Davis HL.
    Vaccine; 2000 Nov 22; 19(7-8):950-7. PubMed ID: 11115721
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
    Diwan M, Tafaghodi M, Samuel J.
    J Control Release; 2002 Dec 13; 85(1-3):247-62. PubMed ID: 12480329
    [Abstract] [Full Text] [Related]

  • 13. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.
    J Immunol; 1998 Jan 15; 160(2):870-6. PubMed ID: 9551923
    [Abstract] [Full Text] [Related]

  • 14. T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch.
    Mongini PK, Paul WE, Metcalf ES.
    J Exp Med; 1982 Mar 01; 155(3):884-902. PubMed ID: 6977611
    [Abstract] [Full Text] [Related]

  • 15. Immune responses to T-dependent and T-independent antigens during visceral leishmaniasis in mice: evidence for altered T-cell regulation of immune responses to non-parasite antigens.
    Reed SG, Roters SB, Inverso JA, Jones TC, Goidl EA.
    Cell Immunol; 1985 Nov 01; 96(1):12-25. PubMed ID: 2424616
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody.
    Chen W, Yu Y, Shao C, Zhang M, Wang W, Zhang L, Cao X.
    Immunol Lett; 2001 May 01; 77(1):17-23. PubMed ID: 11348665
    [Abstract] [Full Text] [Related]

  • 17. Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens.
    Koch G, Lok BD, Benner R.
    Immunobiology; 1982 Dec 01; 163(5):484-96. PubMed ID: 6984419
    [Abstract] [Full Text] [Related]

  • 18. Immunoregulation in the rat: ontogeny of B cell responses to types 1, 2, and T-dependent antigens.
    Kimura S, Eldridge JH, Michalek SM, Morisaki I, Hamada S, McGhee JR.
    J Immunol; 1985 May 01; 134(5):2839-46. PubMed ID: 2580000
    [Abstract] [Full Text] [Related]

  • 19. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll.
    Goud SN, Muthusamy N, Subbarao B.
    J Immunol; 1988 May 01; 140(9):2925-30. PubMed ID: 3129503
    [Abstract] [Full Text] [Related]

  • 20. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.
    Bernard MP, Phipps RP.
    Clin Immunol; 2007 Nov 01; 125(2):138-48. PubMed ID: 17728187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.